ChemicalBook > Product Catalog >API >Synthetic Anti-infective Drugs >Antiviral drugs >methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Request For Quotation
methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate Suppliers list
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696，15000506266 15000506266
Email:
Company Name: Shanghai Xiang Xin Industrial Co., Ltd.  
Tel: 021-50211651 13651607026;
Email: sales@xxgmpharm.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Jinan elephant international trading co., LTD  
Tel:
Email: 13006575422@163.com
Company Name: Kaixin Chemical (Hong Kong) Limited  
Tel: 010-88886666-01 13112345678
Email: loyson@qq.com

methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate manufacturers

  • Coblopasvir
  • Coblopasvir pictures
  • $119.00
  • 2026-08-08
  • CAS:1312608-46-0
  • Purity: 99.33%
  • Supply Ability: 10g
methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate Basic information
Product Name:methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
Synonyms:Methyl((S)-1-((S)-2-(4-(7-(4-(4-((S))))))1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate;KW-136;methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate;EOS-61274;Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4-[7-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-1,3-benzodioxol-4-yl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester;KW-136,KW136,chronic hepatitis C virus infection,HCV Protease,Coblopasvir,NS5A,Hepatitis C virus,inhibit,KW 136,Inhibitor,pangenotypic regimen,HCV;methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamat
CAS:1312608-46-0
MF:C41H50N8O8
MW:782.88
EINECS:
Product Categories:
Mol File:1312608-46-0.mol
methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate Structure
methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate Chemical Properties
storage temp. Store at -20°C
solubility DMF: 3 mg/mL; DMSO: 10 mg/mL; Ethanol: Slightly soluble
form A solid
Safety Information
MSDS Information
methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate Usage And Synthesis
UsesCoblopasvir (KW-136) is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir can be used for research of chronic hepatitis C virus infection[1].
References[1] Gao Y, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial. Liver Int. 2020;40(11):2685-2693. DOI:10.1111/liv.14633
methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate Preparation Products And Raw materials
Tag:methyl((S)-1-((S)-2-(4-(7-(4-(2-((S)-1-((methoxycarbonyl)-D-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate(1312608-46-0) Related Product Information
MYRIOCIN Pradefovir Coblopasvir hydrochloride Narlaprevir LCQ-908 E2/envelope protein, hepatitis C virus (278a.a, HEK293, his)